Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taisuke Ito

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Journal of Dermatological Science|May 8, 2014
Induction of cytotoxic T cells as a novel independent survival factor in malignant melanoma with percutaneous peptide immunizationToshiharu Fujiyama, Isao Oze, Hiroaki Yagi, et al.
Dermatology and Therapy|September 14, 2023
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 StudyDiamant Thaçi, Christos Tziotzios, Taisuke Ito, et al.
Journal of Dermatological Science|September 17, 2013
Increased frequencies of Th17 cells in drug eruptionsToshiharu Fujiyama, Chika Kawakami, Kazunari Sugita, et al.
American Journal of Clinical Dermatology|March 1, 2023
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)Ohsang Kwon, Maryanne M Senna, Rodney Sinclair, et al.
The Journal of Dermatology|June 23, 2007
Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgarisHideo Hashizume, Taisuke Ito, Hiroaki Yagi, et al.
Acta Dermato-Venereologica|January 24, 2019
Therapeutic Effectiveness of Immunoradiotherapy on Brain-metastatic BRAF/MEK Inhibitor-resistant Melanoma with Balloon Cell ChangeHaruka Goto, Takatoshi Shimauchi, Kensuke Fukuchi, et al.
Journal of the American Academy of Dermatology|June 9, 2024
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studiesArash Mostaghimi, Justin Ko, Antonella Tosti, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2014
Proteome analysis of stratum corneum from atopic dermatitis patients by hybrid quadrupole-orbitrap mass spectrometerJun-Ichi Sakabe, Koji Kamiya, Hayato Yamaguchi, et al.
The Journal of Investigative Dermatology|January 15, 2016
Identification and Characterization of a Recessive Missense Mutation p.P277L in SERPINB7 in Nagashima-Type Palmoplantar KeratosisAiko Shiohama, Takashi Sasaki, Showbu Sato, et al.
The Journal of Dermatology|March 12, 2025
Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trialXingqi Zhang, Yanting Ye, Weiling Sun, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Journal of Dermatological Science|May 8, 2014
Induction of cytotoxic T cells as a novel independent survival factor in malignant melanoma with percutaneous peptide immunizationToshiharu Fujiyama, Isao Oze, Hiroaki Yagi, et al.
Dermatology and Therapy|September 14, 2023
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 StudyDiamant Thaçi, Christos Tziotzios, Taisuke Ito, et al.
Journal of Dermatological Science|September 17, 2013
Increased frequencies of Th17 cells in drug eruptionsToshiharu Fujiyama, Chika Kawakami, Kazunari Sugita, et al.
American Journal of Clinical Dermatology|March 1, 2023
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)Ohsang Kwon, Maryanne M Senna, Rodney Sinclair, et al.
The Journal of Dermatology|June 23, 2007
Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgarisHideo Hashizume, Taisuke Ito, Hiroaki Yagi, et al.
Acta Dermato-Venereologica|January 24, 2019
Therapeutic Effectiveness of Immunoradiotherapy on Brain-metastatic BRAF/MEK Inhibitor-resistant Melanoma with Balloon Cell ChangeHaruka Goto, Takatoshi Shimauchi, Kensuke Fukuchi, et al.
Journal of the American Academy of Dermatology|June 9, 2024
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studiesArash Mostaghimi, Justin Ko, Antonella Tosti, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2014
Proteome analysis of stratum corneum from atopic dermatitis patients by hybrid quadrupole-orbitrap mass spectrometerJun-Ichi Sakabe, Koji Kamiya, Hayato Yamaguchi, et al.
The Journal of Investigative Dermatology|January 15, 2016
Identification and Characterization of a Recessive Missense Mutation p.P277L in SERPINB7 in Nagashima-Type Palmoplantar KeratosisAiko Shiohama, Takashi Sasaki, Showbu Sato, et al.
The Journal of Dermatology|March 12, 2025
Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trialXingqi Zhang, Yanting Ye, Weiling Sun, et al.
Pageof 15